Satoshi Kitamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Satoshi Kitamura has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Tetsuyoshi Horiuchi
Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan
6 shared publications - Jun-Ichi Koyama
Neuroendovascular Therapy Center, Shinshu University Hospital, Matsumoto, Japan
5 shared publications - Yoshiki Hanaoka
Department of Neurosurgery, Ina Central Hospital, Ina, Japan
4 shared publications - Daisuke Yamazaki
Department of Neurosurgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan
3 shared publications - Takuya Nakamura
Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan
3 shared publications - Yoshiki Ishii
Lungs for Living, UCL, London, UK
3 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in World Neurosurgery: X
- Vol. 32
Angiographic changes in radial artery narrowing following intra-arterial vasodilator administration during transradial neuroendovascular procedures
- 29 July 2026
- Published by Elsevier in World Neurosurgery: X
- Vol. 32
Open AccessAngiographic changes in radial artery narrowing following intra-arterial vasodilator administration during transradial neuroendovascular procedures
- Open Access
- 16 January 2026
- Published by Elsevier in World Neurosurgery
- Vol. 208, 124804
Micro-Balloon Anchoring Technique: A Universal Solution for Navigational Difficulties of Straight-Shaped Balloon Guide Catheters in Carotid Artery Stenting
- 16 January 2026
- Published by Elsevier in World Neurosurgery
- Vol. 208, 124804
Open AccessMicro-Balloon Anchoring Technique: A Universal Solution for Navigational Difficulties of Straight-Shaped Balloon Guide Catheters in Carotid Artery Stenting
- 23 August 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 51 (2) , 214-219
A new very-small-bore Simmons guiding sheath for transradial neurointervention: Technical note and initial experience
- 23 August 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 51 (2) , 214-219
A new very-small-bore Simmons guiding sheath for transradial neurointervention: Technical note and initial experience
- 22 June 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (2) , 217-222
Real-time angiography in endovascular revascularization of intracranial atherosclerotic internal carotid artery stenosis under proximal balloon protection: “Retrograde suction-injection” technique and literature review
- 22 June 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (2) , 217-222
Real-time angiography in endovascular revascularization of intracranial atherosclerotic internal carotid artery stenosis under proximal balloon protection: “Retrograde suction-injection” technique and literature review
- 10 January 2022
- Published by Elsevier in World Neurosurgery
- Vol. 160, e314-e321
Intraoperative Image-Guided Surgery for Gliomas in the Smart Cyber Operating Theater (SCOT): A Preliminary Clinical Application
- 10 January 2022
- Published by Elsevier in World Neurosurgery
- Vol. 160, e314-e321
Intraoperative Image-Guided Surgery for Gliomas in the Smart Cyber Operating Theater (SCOT): A Preliminary Clinical Application
- 1 December 2001
- Published by Wiley in Respirology
- Vol. 6 (4) , 331-340
Longitudinal follow‐up study of 11 patients with pulmonary lymphangioleiomyomatosis: Diverse clinical courses of LAM allow some patients to be treated without anti‐hormone therapy
Objective: The purpose of this study is to clarify the existing issues on the clinical diversity, natural history, and mode of disease progression of pulmonary lymphangioleiomyomatosis (LAM).Methodology: Eleven patients with LAM were reviewed retrospectively with special reference to serial changes in pulmonary function and radiological findings during the course of their disease, treatment, and outcome. All patients were female with a mean age of 33.8 years at presentation and the observation period ranged from 2.1 to 20.8 years (mean 7.4 years).Results: Four of six patients, treated with anti‐hormone therapy, presented with exertional dyspnoea, marked airflow limitation (forced expiratory volume in 1 s/forced vital capacity, 23–38%), and severely impaired diffusing capacity (%DLCO, 21.4–36% of the predicted). The remaining two patients showed only a decreased diffusing capacity (70.6% and 59.4% of the predicted) which rapidly deteriorated with subsequent development of airflow limitation. Repeated chest computed tomographic (CT) examinations revealed increasing numbers of cysts with simultaneous loss of normal lung parenchyma in these two patients. In contrast, the five patients who received no anti‐hormone therapy had no respiratory symptoms aside from pneumothorax at onset. Remarkable differences were noted, with pulmonary function being well maintained and slow progression of cystic changes on CT being observed in the latter group.Conclusions: Diverse clinical courses observed in patients with pulmonary LAM can be well delineated and assessed by periodic examinations including pulmonary function tests and chest CT imaging. Anti‐hormone therapy is not always necessary for a certain group of LAM patients and they appear to have a stable course and favourable outcomes without anti‐hormone treatment.
- 1 December 2001
- Published by Wiley in Respirology
- Vol. 6 (4) , 331-340
Longitudinal follow‐up study of 11 patients with pulmonary lymphangioleiomyomatosis: Diverse clinical courses of LAM allow some patients to be treated without anti‐hormone therapy
Objective: The purpose of this study is to clarify the existing issues on the clinical diversity, natural history, and mode of disease progression of pulmonary lymphangioleiomyomatosis (LAM).Methodology: Eleven patients with LAM were reviewed retrospectively with special reference to serial changes in pulmonary function and radiological findings during the course of their disease, treatment, and outcome. All patients were female with a mean age of 33.8 years at presentation and the observation period ranged from 2.1 to 20.8 years (mean 7.4 years).Results: Four of six patients, treated with anti‐hormone therapy, presented with exertional dyspnoea, marked airflow limitation (forced expiratory volume in 1 s/forced vital capacity, 23–38%), and severely impaired diffusing capacity (%DLCO, 21.4–36% of the predicted). The remaining two patients showed only a decreased diffusing capacity (70.6% and 59.4% of the predicted) which rapidly deteriorated with subsequent development of airflow limitation. Repeated chest computed tomographic (CT) examinations revealed increasing numbers of cysts with simultaneous loss of normal lung parenchyma in these two patients. In contrast, the five patients who received no anti‐hormone therapy had no respiratory symptoms aside from pneumothorax at onset. Remarkable differences were noted, with pulmonary function being well maintained and slow progression of cystic changes on CT being observed in the latter group.Conclusions: Diverse clinical courses observed in patients with pulmonary LAM can be well delineated and assessed by periodic examinations including pulmonary function tests and chest CT imaging. Anti‐hormone therapy is not always necessary for a certain group of LAM patients and they appear to have a stable course and favourable outcomes without anti‐hormone treatment.
- Open Access
- 1 January 1999
- Published by Japanese Society of Inflammation and Regeneration in Ensho
- Vol. 19 (4) , 203-206
The inhibitory effect of N-acetylcysteine (NAC) on TNF.ALPHA. production from rat alveolar macrophages stimulated by lypopolysaccharide (LPS).
- 1 January 1999
- Published by Japanese Society of Inflammation and Regeneration in Ensho
- Vol. 19 (4) , 203-206
Open AccessThe inhibitory effect of N-acetylcysteine (NAC) on TNF.ALPHA. production from rat alveolar macrophages stimulated by lypopolysaccharide (LPS).
- Open Access
- 1 January 1998
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 37 (3) , 292-294
Multiple Pulmonary Metastases with Cavitation from Gallbladder Cancer.
We report a rare case of multiple pulmonary metastases with cavitation from gallbladder cancer. A 77-year-old woman was admitted to our hospital complaining of productive cough and exertional dyspnea. Chest X-ray film showed multiple nodular shadows with some cavitation. Computed tomography showed multiple cavities, up to 2 cm in diameter, as well as nodules, in bilateral lung fields. Under a survey of primary focus, the ultrasonographic test of the abdomen revealed a hypoechoic mass in the hepatic hilum. The patient died of respiratory failure. Autopsy findings revealed that that multiple lung tumors had metastasized from papillary adenocarcinoma of the gallbladder and that cavitation of the lung was formed by bronchioloectasis.
- 1 January 1998
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 37 (3) , 292-294
Open AccessMultiple Pulmonary Metastases with Cavitation from Gallbladder Cancer.
We report a rare case of multiple pulmonary metastases with cavitation from gallbladder cancer. A 77-year-old woman was admitted to our hospital complaining of productive cough and exertional dyspnea. Chest X-ray film showed multiple nodular shadows with some cavitation. Computed tomography showed multiple cavities, up to 2 cm in diameter, as well as nodules, in bilateral lung fields. Under a survey of primary focus, the ultrasonographic test of the abdomen revealed a hypoechoic mass in the hepatic hilum. The patient died of respiratory failure. Autopsy findings revealed that that multiple lung tumors had metastasized from papillary adenocarcinoma of the gallbladder and that cavitation of the lung was formed by bronchioloectasis.